Automatic Website Traffic RSS

Scientists identify targets to protect against anthracycline-induced cardiotoxicity

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified the mechanisms through which anthracyclines, a widely used class of anticancer drugs, damage the hearts of ... read more

ACE inhibitor not protective against heart damage from chemotherapy

Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracycline chemotherapy did not show any difference in troponin T levels, a ... read more

Moleculin Biotech Says EMA Grants Orphan Drug Designation To Annamycin To Treat AML

Pharmaceutical company Moleculin Biotech, Inc. (MBRX) announced Thursday that the European Medicines Agency (EMA) has granted Orphan ... read more

CNS Pharmaceuticals to Present at the LSX World Congress 2024

HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ... read more

Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties

Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today ... read more

Moleculin Biotech Reveals Positive Anti-cancer Data For Annamycin With Non-cardiotoxic Effects

Clinical stage pharmaceutical company Moleculin Biotech, Inc. (MBRX) Wednesday revealed positive preclinical data, demonstrating high ... read more

Heart disease: How the DASH diet can help lower the risk after breast cancer treatment

Researchers say women who've been treated for breast cancer can lower their risk of cardiovascular disease by following the DASH and other healthy diets ... read more

Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicity

The PROACT trial assessing enalapril in patients with cancer undergoing chemotherapy showed this approach did not affect cardiac function or the rate of cardiac injury. read more

Which ASX companies are resurrecting abandoned drugs? Part 1

Race Oncology (ASX:RAC) is among ASX-listed biotechs resurrecting or repurposing abandoned or underutilised drugs. read more

Riding the 'Boob Bus'; Prior Authorization Pushback; Cancer Warning for Alcohol?

An FDA advisory committee recommended accepting minimal residual disease as a primary endpoint for trials supporting accelerated approvals in multiple myeloma, potentially paving the way for the ... read more

Tinygemsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO To Present At LSX World Congress 2024

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic canc ... read more

Healthy diet lowers heart disease risk in breast cancer survivors, study finds

A new paper in JNCI Cancer Spectrum finds that following a healthy diet lowers the risk of cardiovascular disease in breast cancer survivors. read more